The combination of PD-1+ tumour cells and high PD-L1+ group was related to shorter survival in AITL patients (p = 0.051), but not PTCL-NOS [20]. This evidence concerns the gene PDCD1 and mature T-cell and NK-cell non-Hodgkin lymphoma.